Answer
Ibandronic acid reduces bone resorption by acting selectively on bone tissue and inhibiting osteoclast activity without directly affecting bone formation or interfering with osteoclast recruitment.
Sources for this answer
- Ibandronic acid 150 mg Film-coated TabletsSandoz Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 12Document updated
Sources checked